New investors of Arrayit Corporation [OTC: ARYC] Please review this extensive due diligence report on Silicon Valley biotech ARYC board
Arrayit CLIA clinical team confirms July 2 2018 meeting with the United States Food and Drug Administration FDA to discuss FDA clearance of a major microarray product line
Expect to see an impressive PR this week in regards to this meeting with the FDA.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.